Haiquan Chen - Concepedia

Author

Haiquan Chen

Fudan University Shanghai Cancer Center ORCID

Also Known As

Chen, Haiquan, Cheng, Xinghua, Chun Chen, Hai-Quan Chen, Hai-quan Chen, Haiquan Chen, Ku, Wei-Shinn, Lei Shen, Xinghua Cheng, Yang Zhang

458

Publications

14.2K

Citations

H-Index

133

Concepts

All Affiliations

Fudan University Shanghai Cancer Center Shanghai Medical College of Fudan University Fudan University Shanghai Chest Hospital Center for Excellence in Molecular Cell Science

About

Haiquan Chen is an author at Fudan University Shanghai Cancer Center specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	85	5.2K
2	Health Sciences	13	17	787
3	Engineering	9	9	533
4	Management	3	3	39
5	Natural Sciences	1	1	20

Haiquan Chen

161

Publications

11.7K

Citations

H-Index

Page 1

	Year	Citations
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers Kristin Bergethon, Alice T. Shaw, Sai‐Hong Ignatius Ou, Journal of Clinical Oncology	2012	1.5K
<i>RET</i> Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer Rui Wang, Haichuan Hu, Yunjian Pan, Journal of Clinical Oncology	2012	543
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry Wenhua Liang, Jiaxi He, Yaxing Shen, Journal of Clinical Oncology Surgical OncologyEpidemiology Of CancerThreshold Eln CountPathologyCancer Registration	2017	353
Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases Yihua Sun, Yan Ren, Zhaoyuan Fang, Journal of Clinical Oncology	2010	329
Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial Dongsheng Yue, Shidong Xu, Qun Wang, The Lancet Respiratory Medicine MedicinePathologyErlotinib Versus VinorelbineCancer TreatmentCancer Genetics	2018	288
VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex Wenjing Zhang, Yijun Gao, Peixue Li, Cell Research Transcriptional RegulationCell RegulationMedicineYap-tead Transcriptional ComplexCancer Cell Biology	2014	287
Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype Ting Ye, Shengping Wang, Jiaqing Xiang, Journal of Thoracic Oncology MedicineHistopathologyPathologyBronchial NeoplasmLung Adenocarcinomas Manifesting	2019	279
Automated Diabetic Retinopathy Detection Based on Binocular Siamese-Like Convolutional Neural Network Xianglong Zeng, Haiquan Chen, Yuan Luo, IEEE Access Diabetic RetinopathyImage ClassificationImage AnalysisMachine VisionOphthalmology	2019	279
Genomic and immune profiling of pre-invasive lung adenocarcinoma Haiquan Chen, Jian Carrot‐Zhang, Yue Zhao, Nature Communications	2019	272
Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers Chenguang Li, Rong Fang, Yihua Sun, PLoS ONE	2011	209

Page 1